Related Experiment Video
Updated: May 16, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
[Inhibitive mechanisms of Pim-3 affecting fulminant hepatic apoptosis]
Liang-ming Liu1, Shui-lin Sun, Chang-gen Ye
1Department of Liver Diseases, Songjiang Hospital Affiliated to the First People's Hospital, Shanghai Jiaotong University, China. liuliangming@hotmail.com
Abstract:
To investigate the mechanisms of serine/threonine kinase Pim-3 inhibition of fulminant hepatic apoptosis. Thirty-two rats were randomly divided into four groups (n = 8 each): normal controls (A); pretreatment with Ringer's solution (B), vector plasmid (C), or Pim-3 recombinant plasmid (D) by hydrodynamics-based procedure followed by intraperitoneal injections of lipopolysaccharide (LPS) and D-galactosamine (D-GalN) after one day. At 8 h after the LPS/D-GalN injections, liver tissues were collected from all groups of mice and analyzed for cell apoptosis by detecting caspase-3 activity (measured in relative fluorescence units, RFU). Changes in expression of relevant genes were determined by RT-PCR and Western blotting. Caspase-3 activity was induced in response to LPS/D-GalN injection. Pim-3-pretreated rats showed a lower level of caspase-3 activity than the Ringer's-pretreated or vector plasmid-pretreated rats [(141.7+/-13.7)RFU vs. (508.1+/-32.0) or (493.5+/-33.1) RFU; all P less than 0.01]. High expressions of the liver injury marker gene, iNOS, and the apoptosis-induced genes, p53 and Bax, were found after LPS/D-GalN challenge, and were suppressed by exogenous Pim-3 gene injection. In addition, exogenous Pim-3 gene injection induced high expression of the liver anti-apoptosis protein, Bcl-2, but had no effect on Bax protein expression. The Pim-3 gene can block fulminant hepatic apoptosis by affecting the expression of the iNOS liver injury gene and the p53, Bax and Bcl-2 apoptosis-related genes.
Insights
Serine/threonine kinase Pim-3 inhibits fulminant hepatic apoptosis by modulating apoptosis-related genes. Pim-3 gene injection suppressed liver injury and apoptosis markers, offering a potential therapeutic strategy.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Fulminant hepatic apoptosis is a severe liver condition.
- Serine/threonine kinase Pim-3's role in apoptosis is not fully understood.
- Investigating Pim-3's mechanism in liver injury is crucial for therapeutic development.
Purpose of the Study:
- To investigate the protective mechanisms of serine/threonine kinase Pim-3 against fulminant hepatic apoptosis.
- To determine the effect of Pim-3 gene on apoptosis-related gene expression in a rat model of liver injury.
Main Methods:
- Rats were divided into four groups: control, Ringer's solution, vector plasmid, and Pim-3 recombinant plasmid.
- Fulminant hepatic apoptosis was induced using lipopolysaccharide (LPS) and D-galactosamine (D-GalN).
- Caspase-3 activity, gene expression (RT-PCR), and protein levels (Western blotting) were analyzed.
Main Results:
- Pim-3 pretreatment significantly reduced caspase-3 activity compared to control groups.
- Exogenous Pim-3 gene suppressed the expression of liver injury marker iNOS and apoptosis-related genes p53 and Bax.
- Pim-3 gene upregulated the anti-apoptosis protein Bcl-2 without affecting Bax protein levels.
Conclusions:
- The serine/threonine kinase Pim-3 gene can effectively block fulminant hepatic apoptosis.
- Pim-3 exerts its protective effects by modulating the expression of iNOS, p53, Bax, and Bcl-2.
- Pim-3 shows potential as a therapeutic agent for preventing severe liver apoptosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
